The FDA has approved AstraZeneca's Imfinzi with gemcitabine and cisplatin as neoadjuvant treatment in adults with MIBC.

NorthWest EHealth is a winner in the Innovation, Safety, and Diversity categories in the 2025 Pharmaceutical Excellence ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.

The Ukrainian government has instigated rapid cost-cutting measures across the drug retail sector, triggered by reports of ...

Completed biopharma IPOs that raised more than $100 million saw a twofold increase during the year. Biopharmaceutical initial ...

For cell and gene therapy, a consistent supply of quality starting material is vital that is maintained throughout the ...

Non-profit organisations provide an alternative to rescue stalled orphan drugs for biotechs struggling against a lethargic ...

Vertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.

Use of GLP-1RA therapies in CV/CKD disease with T2D will likely rise as physicians view them as addressers of cardiometabolic ...

Based on the Phase II data, Imbria Pharmaceuticals’ inerafaxstat could complement existing treatments rather than replace them.